The National Institute of Health, a global leader in medical research, announced that they would be cutting research grants to universities, specifically the indirect cost rate to just 15% due to a rule change prompted by the Trump administration, according to their policy statement released on Friday, Feb. 7. The indirect cost rate is the percentage of a research grant that can be allocated to indirect costs like equipment, operations and maintenance. This new rate is a dramatic decrease from the University of Connecticut’s current negotiated rate of 61% and UConn Health’s rate of 66.5%, as reported by UConn Today.
UConn is currently considered a R1 Institution by the American Council on Education and Carnegie Foundation for the Advancement of Teaching. This means that UConn is a leader in research spending and doctorate production, home to over 1,000 graduate students on grants and have won $368 million in new awards in 2024. With significantly less funding, UConn’s research potential and status as a Research 1 Institution may be at risk.
With limited indirect funding from the NIH, university research programs are left with few options to make up for the loss. The funding is critical to maintaining labs, providing supplies and paying support staff. Should the change be implemented, UConn and other universities would be forced to cut programs or cut corners in their research process, according to Holden Thorp, chemistry professor and former chancellor of the University of North Carolina at Chapel Hill. Alternatively, the costs could be passed on to taxpayers, included in state appropriations or cause a rise in tuition for students, according to a statement by UConn.
The impact this will have on academia is incredibly significant. In each case, if tuition rises to cover research costs or if these costs are simply not encumbered by the university, this transition costs onto students and prospective researchers, effectively making it harder for those without resources to enter these fields. It is not easy to participate in research while studying, especially for those who have costs that they must work to pay for. The benefit of grants and research stipends is that it allows for diverse ranges of students to be able to do substantial academic work while not having to stress financially or work extra time on other jobs. If only those with financial means are fiscally capable of doing research, then that will affect what questions are being asked and what research is being done. It is important for both the state of Connecticut and UConn to prioritize ensuring accessibility in academia as these events develop. These cuts are not the first movements made by the current Trump administration that affect higher education, but they are the first to directly impact funding for research. The decision to strip universities of millions of dollars in funding shows a lack of respect for academic excellence and the researchers who spend time advancing our country’s medical knowledge. The United States did not rank top ten in the 2024 World Index of Healthcare Innovation through discouraging research. UConn did not jump nine places in the annual Higher Education Research and Development Survey by reducing research expenditures. Universities and students nationwide deserve a dependable source of funding for their projects.
With a planned implementation date of Feb. 10, District Judge Angel Kelley temporarily blocked the rate cut after 22 states, including Connecticut, filed lawsuits. While UConn will retain its current rate for now, our research programs and status as an R1 institution remain in danger. It is imperative that lawmakers work toward finding sustainable policies that do not harm universities and students. We also encourage students, faculty and community members to stay informed and make their voices heard. Advocate for policies that support funding for higher education. The status of our school and our country depend on it.